Online Purchasing Account You are logged on as Guest. Login Register a New Account Shopping cart (Empty)

ALK5 Inhibitor I



ALX-270-448-M001	1 mg	87.00 USD

ALX-270-448-M005	5 mg	127.00 USD
Do you need bulk/larger quantities?

Cell permeable, potent, selective and ATP-competitive inhibitor of TGF-β RI kinase (IC₅₀=51nM). Displays ~15-fold greater selectivity over p38α MAPK (IC₅₀=740nM). Inhibits TGF-β-dependent cellular growth (IC50=89nM in NIH 3T3 mouse fibroblasts) and transcription activation (IC₅₀=47nM in mink lung cells). Suppresses invasion of MDA-MB-231 breast cancer cells in a matrigel invasion assay.

Product Details

Alternative Name:	TGF-β RI Kinase Inhibitor I, 3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole

Formula:	C₁₇H₁₂N₄

MW:	272.3

CAS:	396129-53-6

Purity:	≥97% (TLC)

Appearance:	Yellow to brown solid.

Solubility:	Soluble in DMSO or methanol.

Shipping:	Ambient

Long Term Storage:	-20°C

Use/Stability:	Stable for 2 years after receipt when stored at -20°C. Stock solutions are stable for up to 3 months when stored at -20°C.

Handling:	Protect from light.

Regulatory Status:	RUO - Research Use Only

Please mouse over

Product Literature References

Chemically defined conditions for long-term maintenance of pancreatic progenitors derived from human induced pluripotent stem cells: S. Konagaya, et al.; Sci. Rep. 9, 640 (2019), Abstract; Full Text

Closed-channel culture system for efficient and reproducible differentiation of human pluripotent stem cells into islet cells: K. Hirano, et al.; Biochem. Biophys. Res. Commun. 487, 344 (2017), Application(s): hiPSC line 253G1, Abstract;

Emdogain-regulated gene expression in palatal fibroblasts requires TGF-βRI kinase signaling: A. Stähli, et al.; PLoS One 9, e105672 (2014), Abstract; Full Text

Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI): J. Singh, et al.; Bioorg. Med. Chem. Lett. 13, 4355 (2003), Abstract;

Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain: J.S. Sawyer, et al.; J. Med. Chem. 46, 3953 (2003), Abstract;